Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Anika Therapeutics (ANIK) Return on Sales: 2009-2024

Historic Return on Sales for Anika Therapeutics (ANIK) over the last 16 years, with Dec 2024 value amounting to -0.40%.

  • Anika Therapeutics' Return on Sales fell 3.00% to -0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.17%, marking a year-over-year decrease of 3.00%. This contributed to the annual value of -0.40% for FY2024, which is 26.00% up from last year.
  • Anika Therapeutics' Return on Sales amounted to -0.40% in FY2024, which was up 39.53% from -0.66% recorded in FY2023.
  • Anika Therapeutics' Return on Sales' 5-year high stood at 0.05% during FY2021, with a 5-year trough of -0.66% in FY2023.
  • For the 3-year period, Anika Therapeutics' Return on Sales averaged around -0.40%, with its median value being -0.40% (2024).
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by 51bps in 2023, then increased by 26bps in 2024.
  • Over the past 5 years, Anika Therapeutics' Return on Sales (Yearly) stood at -0.18% in 2020, then rose by 23bps to 0.05% in 2021, then declined by 19bps to -0.15% in 2022, then tumbled by 51bps to -0.66% in 2023, then rose by 26bps to -0.40% in 2024.